Carisma Therapeutics (CARM)
NASDAQ:CARM
Holding CARM?
Track your performance easily

Carisma Therapeutics (CARM) Technical Analysis

1,537 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Carisma Therapeutics’s (CARM) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Carisma Therapeutics is a Sell.
Carisma Therapeutics’s (CARM) 20-Day exponential moving average is 1.01, while Carisma Therapeutics’s (CARM) share price is $1.01, making it a Sell.
Carisma Therapeutics’s (CARM) 50-Day exponential moving average is 1.02, while Carisma Therapeutics’s (CARM) share price is $1.01, making it a Sell.

Carisma Therapeutics (CARM) Pivot Points

Nov 10, 2024, 03:54 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.95
0.99
1.01
1.05
1.07
1.11
1.13
Fibonacci
0.99
1.01
1.03
1.05
1.07
1.09
1.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Carisma Therapeutics (CARM) Moving Averages

Nov 10, 2024, 03:54 AM
Period
Simple
Exponential
MA5
1.06Sell
1.04Sell
MA10
1.03Sell
1.03Sell
MA20
1.00Buy
1.01Sell
MA50
0.99Buy
1.02Sell
MA100
1.06Sell
1.13Sell
MA200
1.48Sell
1.53Sell
Carisma Therapeutics’s (CARM) 10-Day exponential moving average is 1.03, while Carisma Therapeutics’s (CARM) share price is $1.01, making it a Sell.
Carisma Therapeutics’s (CARM) 100-Day exponential moving average is 1.13, while Carisma Therapeutics’s (CARM) share price is $1.01, making it a Sell.
Carisma Therapeutics’s (CARM) stock price is $1.01 and Carisma Therapeutics’s (CARM) 50-day simple moving average is 0.99, creating a Buy signal.
Carisma Therapeutics’s (CARM) stock price is $1.01 and Carisma Therapeutics’s (CARM) 100-day simple moving average is 1.06, creating a Sell signal.
Carisma Therapeutics’s (CARM) stock price is $1.01 and Carisma Therapeutics’s (CARM) 200-day simple moving average is 1.48, creating a Sell signal.

Carisma Therapeutics (CARM) Technical Indicators

Nov 10, 2024, 03:54 AM
Name
Value
Implied Action
RSI (14)
50.37
Neutral
STOCH (9,6)
52.94
Neutral
STOCHRSI (14)
55.78
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
18.24
Buy
Williams %R
-67.80
Buy
CCI (14)
18.55
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
48.84
Neutral
ROC
3.06
Buy
Carisma Therapeutics’s (CARM) Relative Strength Index (RSI) is 50.37, creating a Neutral signal.
Carisma Therapeutics’s (CARM) Trend Strength Indicator (ADX) is 18.24, creating a Buy signal.
Carisma Therapeutics’s (CARM) Commodity Channel Index (CCI) is 18.55, creating a Neutral signal.
Carisma Therapeutics’s (CARM) Price Rate of Change (ROC) is 3.06, creating a Buy signal.

FAQ

Is CARM a Buy, Hold, or Sell?
Based on CARM’s technical indicators, CARM is a Sell.
    What is CARM’s RSI (14)?
    CARM’s RSI (14) is 50.37, which suggests CARM is a Neutral.
      What is CARM’s MACD?
      CARM’s MACD is 0.02, which suggests CARM is a Sell.
        What is CARM’s 5-day moving average?
        CARM’s 5-day moving average is 1.06, which suggests CARM is a Sell.
          What is CARM’s 20-day moving average?
          CARM 20-day moving average is 1.00, which suggests CARM is a Buy.
            What is CARM’s 50-day moving average?
            CARM’s 50-day moving average is 0.99, which suggests CARM is a Buy.
              What is CARM’s 200-day moving average?
              CARM’s 200-day moving average is 1.48, which suggests CARM is a Sell.
                What is CARM’s Williams % R (14)?
                CARM’s Williams % R (14) is -67.80, which suggests CARM is a Buy.
                  What is CARM’s CCI (14)?
                  CARM’s CCI (14) is 18.55, which suggests CARM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis